Envestnet Asset Management Inc Ginkgo Bioworks Holdings, Inc. Transaction History

Envestnet Asset Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$0.28 - $1.16 $111,293 - $461,070	-397,475 Reduced 44.96%	486,643 $160,000
Q1 2024 May 13, 2024	BUY	$1.06 - $1.67 $183,378 - $288,908	172,999 Added 24.33%	884,118 $1.03 Million
Q4 2023 Feb 13, 2024	BUY	$1.26 - $1.79 $446,404 - $634,177	354,289 Added 99.29%	711,119 $1.2 Million
Q3 2023 Nov 13, 2023	BUY	$1.61 - $2.54 $210,243 - $331,688	130,586 Added 57.72%	356,830 $645,000
Q2 2023 Aug 04, 2023	BUY	$1.14 - $1.95 $130,499 - $223,222	114,473 Added 102.42%	226,244 $420,000
Q1 2023 May 11, 2023	SELL	$1.2 - $2.19 $26,509 - $48,379	-22,091 Reduced 16.5%	111,771 $148,000
Q4 2022 Feb 07, 2023	BUY	$1.63 - $3.52 $1,696 - $3,664	1,041 Added 0.78%	133,862 $226,000
Q3 2022 Nov 10, 2022	BUY	$0.73 - $3.74 $36,294 - $185,945	49,718 Added 59.83%	132,821 $414,000
Q2 2022 Aug 03, 2022	BUY	$2.2 - $4.2 $67,449 - $128,767	30,659 Added 58.46%	83,103 $198,000
Q1 2022 May 04, 2022	BUY	$2.83 - $8.69 $148,416 - $455,738	52,444 New	52,444 $211,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $12.1B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.